From what I saw and did:
Some undervalued Chinese companies with low P/E ratios may work (for now, I’m thinking about PDD), but their growth potential could be cut at any moment—whether by the US or Chinese government(discussed on a thread). I haven’t bought it yet but am keeping a sharp eye on it.
I recently bought NVO after reading about its R&D stages for new drugs—it seems promising. Plus, it faced unfavorable sentiment from the market. Honestly, it was just like in the books: an irrational bearish event created an opportunity to buy $1 for $0.50 or so.
After the recent production report, I considered buying TSLA. However, I’m not enthusiastic about its new model without a steering wheel (it’s ridiculous). While I think it might outperform the S&P, the current price is too high for me. I’ll wait for the next downturn (hopefully a crash or crisis—Black Monday for some, Sunshine Sunday for me).
ARX and ENB from Canada might perform well, especially since I don’t have to pay taxes on their dividends in my case.
What else... I think GOOG could do well with its new chip, but, similar to TSLA, I’m hoping for a price drop—perhaps triggered by selling the Chrome browser.
For now, I don’t have many new ideas, just like you Sir.
*I’m still holding a few positions from last year that I want to get rid of, but I’ll keep RYYAY and STM for now (both are down a little, so I’m aiming for the end of 2025). |
